TP53 is known as a tumor suppressor and has been shown to be repressed in colorectal cancer and SMAD2/3 has been shown to be mutated in most cases of colorectal cancer and possibly most underexpressed [13, 15]. Here, TP53 is linked to colorectal cancer.